Put Options

19 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$9.97 - $14.52 $1.22 Million - $1.77 Million
-122,000 Reduced 93.34%
8,700 $123,000
Q3 2023

Nov 14, 2023

BUY
$11.78 - $13.86 $1.54 Million - $1.81 Million
130,700 New
130,700 $1.59 Million
Q4 2022

Feb 14, 2023

SELL
$9.89 - $12.7 $60,329 - $77,470
-6,100 Reduced 38.85%
9,600 $117,000
Q3 2022

Nov 14, 2022

BUY
$9.82 - $12.75 $146,318 - $189,975
14,900 Added 1862.5%
15,700 $164,000
Q2 2022

Aug 08, 2022

SELL
$6.23 - $11.12 $128,961 - $230,183
-20,700 Reduced 96.28%
800 $9,000
Q1 2022

May 16, 2022

BUY
$7.89 - $12.48 $132,552 - $209,664
16,800 Added 357.45%
21,500 $204,000
Q4 2021

Feb 14, 2022

SELL
$9.82 - $12.44 $414,404 - $524,968
-42,200 Reduced 89.98%
4,700 $54,000
Q3 2021

Nov 15, 2021

SELL
$8.74 - $11.84 $196,650 - $266,400
-22,500 Reduced 32.42%
46,900 $448,000
Q2 2021

Aug 16, 2021

SELL
$8.71 - $10.72 $715,962 - $881,184
-82,200 Reduced 54.22%
69,400 $669,000
Q1 2021

May 17, 2021

BUY
$9.2 - $23.86 $1.25 Million - $3.25 Million
136,400 Added 897.37%
151,600 $1.5 Million
Q4 2020

Feb 16, 2021

BUY
$13.47 - $24.89 $195,315 - $360,905
14,500 Added 2071.43%
15,200 $351,000
Q3 2020

Nov 16, 2020

SELL
$12.89 - $15.89 $20,624 - $25,424
-1,600 Reduced 69.57%
700 $10,000
Q1 2020

May 15, 2020

SELL
$6.63 - $11.16 $25,194 - $42,408
-3,800 Reduced 62.3%
2,300 $21,000
Q4 2019

Feb 14, 2020

BUY
$7.48 - $10.75 $45,628 - $65,575
6,100 New
6,100 $59,000
Q2 2019

Aug 14, 2019

SELL
$10.96 - $14.4 $80,008 - $105,120
-7,300 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$10.04 - $13.92 $483,927 - $670,944
-48,200 Reduced 86.85%
7,300 $99,000
Q4 2018

Feb 14, 2019

BUY
$8.38 - $13.44 $277,378 - $444,864
33,100 Added 147.77%
55,500 $532,000
Q3 2018

Nov 14, 2018

BUY
$11.6 - $16.54 $143,840 - $205,096
12,400 Added 124.0%
22,400 $271,000
Q2 2018

Aug 14, 2018

BUY
$13.13 - $17.09 $131,300 - $170,900
10,000 New
10,000 $156,000

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.7B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.